abstract |
FIELD: medicine. n SUBSTANCE: treatment is characterised combinative application of inhibitor of cholesterol biosynthesis and soluble fibre in effective doses. Component ration is, at least, 100:1 by wt. Inhibitor of cholesterol biosynthesis is chosen from the group consisting of HMG CoA reductase inhibitors, HMG CoA inhibitors synthase and combinations thereof. n EFFECT: safe and effective decholesterolisation in mammals. n 39 cl, 4 ex |